Syros Pharmaceuticals Inc (NASDAQ: SYRS) Is Getting Increasingly Hard To Ignore
Currently, there are 26.83M common shares owned by the public and among those 17.43M shares have been available to trade. The company’s stock has a 5-day price change of 25.10% and -88.36% over the past three months. SYRS shares are trading -96.79% year to date (YTD), with the 12-month market performance down to -96.53% lower. […]
